198 related articles for article (PubMed ID: 27737732)
1. Anacardic acid inhibits gelatinases through the regulation of Spry2, MMP-14, EMMPRIN and RECK.
Nambiar J; Bose C; Venugopal M; Banerji A; Patel TB; Kumar GB; Nair BG
Exp Cell Res; 2016 Nov; 349(1):139-151. PubMed ID: 27737732
[TBL] [Abstract][Full Text] [Related]
2. Solasodine inhibits invasion of human lung cancer cell through downregulation of miR-21 and MMPs expression.
Shen KH; Hung JH; Chang CW; Weng YT; Wu MJ; Chen PS
Chem Biol Interact; 2017 Apr; 268():129-135. PubMed ID: 28283413
[TBL] [Abstract][Full Text] [Related]
3. Decreased RECK and Increased EMMPRIN expression in urothelial carcinoma of the bladder are associated with tumor aggressiveness.
Wittschieber D; Stenzinger A; Klauschen F; Stephan C; Jung K; Erbersdobler A; Rabien A
Pathobiology; 2011; 78(3):123-31. PubMed ID: 21613799
[TBL] [Abstract][Full Text] [Related]
4. Tomatidine inhibits invasion of human lung adenocarcinoma cell A549 by reducing matrix metalloproteinases expression.
Yan KH; Lee LM; Yan SH; Huang HC; Li CC; Lin HT; Chen PS
Chem Biol Interact; 2013 May; 203(3):580-7. PubMed ID: 23566884
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II stimulates cardiac fibroblast migration via the differential regulation of matrixins and RECK.
Siddesha JM; Valente AJ; Sakamuri SS; Yoshida T; Gardner JD; Somanna N; Takahashi C; Noda M; Chandrasekar B
J Mol Cell Cardiol; 2013 Dec; 65():9-18. PubMed ID: 24095877
[TBL] [Abstract][Full Text] [Related]
6. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
Farabegoli F; Papi A; Orlandi M
Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
[TBL] [Abstract][Full Text] [Related]
7. Anacardic acid inhibits the catalytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9.
Omanakuttan A; Nambiar J; Harris RM; Bose C; Pandurangan N; Varghese RK; Kumar GB; Tainer JA; Banerji A; Perry JJ; Nair BG
Mol Pharmacol; 2012 Oct; 82(4):614-22. PubMed ID: 22745359
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of reversion-inducing cysteine-rich protein with Kazal motifs in malignant melanoma: inverse correlation with membrane-type 1-matrix metalloproteinase and tissue inhibitor of metalloproteinase 2.
Jacomasso T; Trombetta-Lima M; Sogayar MC; Winnischofer SM
Melanoma Res; 2014 Feb; 24(1):32-9. PubMed ID: 24335752
[TBL] [Abstract][Full Text] [Related]
9. Calcifying Cystic Odontogenic Tumour: immunohistochemical expression of matrix metalloproteinases, their inhibitors (TIMPs and RECK) and inducer (EMMPRIN).
Prosdócimi FC; Rodini CO; Sogayar MC; Sousa SC; Xavier FC; Paiva KB
J Oral Pathol Med; 2014 Aug; 43(7):545-53. PubMed ID: 24484176
[TBL] [Abstract][Full Text] [Related]
10. RECK (reversion-inducing cysteine-rich protein with Kazal motifs) regulates migration, differentiation and Wnt/β-catenin signaling in human mesenchymal stem cells.
Mahl C; Egea V; Megens RT; Pitsch T; Santovito D; Weber C; Ries C
Cell Mol Life Sci; 2016 Apr; 73(7):1489-501. PubMed ID: 26459448
[TBL] [Abstract][Full Text] [Related]
11. Variations on brain microglial gene expression of MMPs, RECK, and TIMPs in inflammatory and non-inflammatory diseases in dogs.
Stein VM; Puff C; Genini S; Contioso VB; Baumgärtner W; Tipold A
Vet Immunol Immunopathol; 2011 Nov; 144(1-2):17-26. PubMed ID: 21802747
[TBL] [Abstract][Full Text] [Related]
12. Reversion-inducing-cysteine-rich protein with Kazal motif is involved in intimal hyperplasia in carotid arteries: a new insight in the prevention of restenosis after vascular angioplasty.
Liu J; Chi D; Lu H; Zhang T; Yamakawa T
Ann Vasc Surg; 2015 Aug; 29(6):1293-9. PubMed ID: 26004948
[TBL] [Abstract][Full Text] [Related]
13. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers.
Mwaura B; Mahendran B; Hynes N; Defreitas D; Avalos G; Adegbola T; Adham M; Connolly CE; Sultan S
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):306-10. PubMed ID: 16169261
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinases-2, -9 and reversion-inducing cysteine-rich protein with Kazal motifs in gingiva in periodontal health and disease.
Liu N; Cao Y; Zhu G
Arch Oral Biol; 2017 Mar; 75():62-67. PubMed ID: 28043014
[TBL] [Abstract][Full Text] [Related]
15. Preeclampsia associates with RECK-dependent decrease in human trophoblasts migration and invasion.
Gutiérrez J; Aedo A; Mora J; Maldonado J; Salsoso R; Toledo F; Farías M; Pardo F; Leiva A; Sobrevia L
Placenta; 2017 Nov; 59():19-29. PubMed ID: 29108633
[TBL] [Abstract][Full Text] [Related]
16. Correlation of reversion-inducing cysteine-rich protein with kazal motifs (RECK) and extracellular matrix metalloproteinase inducer (EMMPRIN), with MMP-2, MMP-9, and survival in colorectal cancer.
van der Jagt MF; Sweep FC; Waas ET; Hendriks T; Ruers TJ; Merry AH; Wobbes T; Span PN
Cancer Lett; 2006 Jun; 237(2):289-97. PubMed ID: 16046057
[TBL] [Abstract][Full Text] [Related]
17. Estrogen suppresses expression of the matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs (RECK) within the mouse uterus.
Zhang X; Healy C; Nothnick WB
Endocrine; 2012 Aug; 42(1):97-106. PubMed ID: 22302680
[TBL] [Abstract][Full Text] [Related]
18. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
Milner JM; Rowan AD; Cawston TE; Young DA
Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
[TBL] [Abstract][Full Text] [Related]
19. Potential Role of Reversion-Inducing Cysteine-Rich Protein with Kazal Motifs (RECK) in Regulation of Matrix Metalloproteinases (MMPs) Expression in Periodontal Diseases.
Liu N; Zhou B; Zhu G
Med Sci Monit; 2016 Jun; 22():1936-8. PubMed ID: 27272560
[TBL] [Abstract][Full Text] [Related]
20. Gelatinase expression and proteolytic activity in giant-cell arteritis.
Segarra M; García-Martínez A; Sánchez M; Hernández-Rodríguez J; Lozano E; Grau JM; Cid MC
Ann Rheum Dis; 2007 Nov; 66(11):1429-35. PubMed ID: 17502363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
